Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Total 13F shares
-
212,710,438
-
Share change
-
-978,596
-
Total reported value
-
$109,036,688,386
-
Put/Call ratio
-
120%
-
Price per share
-
$512.97
-
Number of holders
-
1,535
-
Value change
-
-$450,450,567
-
Number of buys
-
668
-
Number of sells
-
634
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2022
As of 31 Dec 2022,
Elevance Health, Inc. - Common Stock (ELV) was held by
1,535 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
212,710,438 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Capital International Investors, GEODE CAPITAL MANAGEMENT, LLC, Sanders Capital, LLC, and BAILLIE GIFFORD & CO.
This page lists
1,535
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.